Literature DB >> 10501473

Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.

J J Clifford1, O Tighe, D T Croke, A Kinsella, D R Sibley, J Drago, J L Waddington.   

Abstract

Though D1-like dopamine receptors [D1A/B] are defined in terms of linkage to the stimulation of adenylyl cyclase, with D1A assumed to be the functionally prepotent subtype, evidence suggests the existence of another, novel D1-like receptor without such coupling. To investigate these issues we challenged mutant mice having targeted gene deletion of the D1A receptor with selective agonists and used an ethologically-based assessment technique to resolve resultant behavioural topography. D1-like-dependent behaviour was substantially conserved in D1A-null mice relative to wild-types following challenge with each of two selective D1-like agents: A 68930 (0.068-2.0 mg/kg s.c.) which exhibits full efficacy to stimulate adenylyl cyclase, and SKF 83959 (0.016-2.0 mg/kg s.c.) which fails to stimulate adenylyl cyclase, and indeed inhibits the stimulation of adenylyl cyclase induced by dopamine. Furthermore, responsivity to the selective D2-like agonist RU 24213 (0.1-12.5 mg/kg s.c.) was conserved in D1A-null mice, indicating the integrity of D1-like:D2-like interactions at the level of behaviour. These data are consistent with behavioural primacy of a D1-like receptor other than D1A [or D1B] that is coupled to a transduction system other than/additional to adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501473     DOI: 10.1016/s0306-4522(99)00297-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.

Authors:  John Y F Wong; Jeremiah J Clifford; Jim S Massalas; Anthony Kinsella; John L Waddington; John Drago
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

2.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 3.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 4.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

5.  Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.

Authors:  Rajeev I Desai; John L Neumeyer; Carol A Paronis; Phong Nguyen; Jack Bergman
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

6.  Mice lacking rhes show altered morphine analgesia, tolerance, and dependence.

Authors:  Franklin A Lee; Brandon A Baiamonte; Daniela Spano; Gerald J Lahoste; R Denis Soignier; Laura M Harrison
Journal:  Neurosci Lett       Date:  2010-12-14       Impact factor: 3.046

Review 7.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

8.  Electrophysiological effects of SKF83959 on hippocampal CA1 pyramidal neurons: potential mechanisms for the drug's neuroprotective effects.

Authors:  Hong-Yuan Chu; Qinhua Gu; Guo-Zhang Jin; Guo-Yuan Hu; Xuechu Zhen
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

9.  Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

Authors:  Gerard J O'Sullivan; Mark Dunleavy; Kerstin Hakansson; Mario Clementi; Anthony Kinsella; David T Croke; John Drago; Allen A Fienberg; Paul Greengard; David R Sibley; Gilberto Fisone; David C Henshall; John L Waddington
Journal:  Neuropharmacology       Date:  2008-02-21       Impact factor: 5.250

10.  Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo.

Authors:  Judith Mosinger Ogilvie; Angela M Hakenewerth; Rachel R Gardner; Joshua G Martak; Virginia M Maggio
Journal:  Mol Vis       Date:  2009-12-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.